{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:17:00Z","timestamp":1782922620378,"version":"3.54.5"},"reference-count":34,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Boston Scientific Corporation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endosc Int Open"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n                  Background and study aims Patients with primary sclerosing cholangitis (PSC) have a 9% to 20% lifetime incidence of cholangiocarcinoma (CCA). Per-oral cholangioscopy (POCS) added to endoscopic retrograde cholangiography (ERC) could potentially improve detection of CCA occurrence. We prospectively assessed POCS identification of 12-month CCA incidence in PSC patients undergoing ERC.<\/jats:p><jats:p>\n                  Patients and methods Consecutive patients with PSC, an indication for ERC, and no prior liver transplantation were enrolled. During the index procedure, POCS preceded planned therapeutic maneuvers. The primary endpoint was ability for POCS visualization with POCS-guided biopsy to identify CCA during 12-month follow-up. Secondary endpoints included ability of ERC\/cytology to identify CCA, repeat ERC, liver transplantation, and serious adverse events (SAEs).<\/jats:p><jats:p>\n                  Results Of 42 patients enrolled, 36 with successful cholangioscope advancement were analyzed. Patients had a mean age 43.5\u00b115.6 years and 61% were male. Three patients diagnosed with CCA had POCS visualization impressions of benign\/suspicious\/suspicious, and respective POCS-guided biopsy findings of suspicious\/positive\/suspicious for malignancy at the index procedure. The three CCA cases had ERC visualization impressions of benign\/benign\/suspicious, and respective cytology findings of atypical\/atypical\/suspicious for malignancy. No additional patients were diagnosed with CCA during median 11.5-month follow-up. Twenty-three repeat ERCs (5 including POCS) were performed in 14 patients. Five patients had liver transplantation, one after CCA diagnosis and four after benign cytology at the index procedure. Three patients (7.1%) had post-ERC pancreatitis. No SAEs were POCS-related.<\/jats:p><jats:p>\n                  Conclusions In PSC patients, POCS visualization\/biopsy and\n      ERC\/cytology each identified three cases of CCA. Some patients had a repeat procedure and none\n      experienced POCS-related SAEs.<\/jats:p>","DOI":"10.1055\/a-2236-7557","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T23:45:15Z","timestamp":1704239115000},"page":"E237-E244","source":"Crossref","is-referenced-by-count":3,"title":["Per-oral cholangioscopy in patients with primary sclerosing cholangitis: a 12-month follow-up study"],"prefix":"10.1055","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct03766035","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Rachid","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooraj","family":"Tejaswi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, University of California Davis School of Medicine, Sacramento, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Aabakken","sequence":"additional","affiliation":[{"name":"Dept of Transplantation Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyriel Y","family":"Ponsioen","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L","family":"Bowlus","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, University of California Davis School of Medicine, Sacramento, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G","family":"Adler","sequence":"additional","affiliation":[{"name":"Center for Advanced Therapeutic Endoscopy, Adventist Porter Hospital, Denver,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nauzer","family":"Forbes","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vemund","family":"Paulsen","sequence":"additional","affiliation":[{"name":"Dept of Transplantation Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9969-019X","authenticated-orcid":false,"given":"Rogier P.","family":"Voermans","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Urayama","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, University of California Davis School of Medicine, Sacramento, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Peetermans","sequence":"additional","affiliation":[{"name":"Clinical Endoscopy, Boston Scientific Corporation, Marlborough, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Rousseau","sequence":"additional","affiliation":[{"name":"Clinical Endoscopy, Boston Scientific Corporation, Marlborough, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertus","family":"Eksteen","sequence":"additional","affiliation":[{"name":"Gastroenterology, Aspen Woods Clinic, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"JK Dyson","year":"2018","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12016-019-08764-7","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC): a comprehensive review","volume":"58","author":"J Song","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.5604\/01.3001.0010.5274","article-title":"Endoscopic management of primary sclerosing cholangitis","volume":"16","author":"JA Barkin","year":"2017","journal-title":"Ann Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","article-title":"AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review","volume":"17","author":"CL Bowlus","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"CL Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","article-title":"Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process","volume":"161","author":"CY Ponsioen","year":"2021","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline","volume":"49","author":"L Aabakken","year":"2017","journal-title":"Endoscopy"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.vgie.2021.01.009","article-title":"Cholangioscopy in primary sclerosing cholangitis: a case series of dominant strictures and cholangiocarcinoma","volume":"6","author":"S Tejaswi","year":"2021","journal-title":"VideoGIE"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/hep.23277","article-title":"Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis","volume":"51","author":"SY Bangarulingam","year":"2010","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.gie.2013.11.001","article-title":"Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"U Navaneethan","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s10620-019-05866-2","article-title":"Cholangioscopy biopsies improve detection of cholangiocarcinoma when combined with cytology and FISH, but not in patients with PSC","volume":"65","author":"K Kaura","year":"2020","journal-title":"Dig Dis Sci"},{"key":"ref12","first-page":"42","article-title":"Cholangioscopy and its Role in Primary Sclerosing Cholangitis","volume":"8","author":"BM Fung","year":"2020","journal-title":"Eur Med J Hepatol"},{"key":"ref13","first-page":"127","article-title":"Peroral cholangioscopy facilitates targeted tissue acquisition in patients with suspected cholangiocarcinoma","volume":"60","author":"R Liu","year":"2014","journal-title":"Minerva Gastroenterol Dietol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.gie.2013.09.017","article-title":"Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP","volume":"79","author":"N Azeem","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"P Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"AB598","DOI":"10.1016\/j.gie.2016.03.1242","article-title":"Tu1534 Detection of cholangiocarcinoma in patients with primary sclerosing cholangitis using single-operator cholangioscopy: a prospective evaluation and cost analysis","volume":"83","author":"N Forbes","year":"2016","journal-title":"Gastrointestinal Endoscopy"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/1756283X14564674","article-title":"Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma","volume":"8","author":"A Nanda","year":"2015","journal-title":"Therap Adv Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2007.01776.x","article-title":"Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures","volume":"103","author":"MJ Levy","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"CY Ponsioen","year":"2002","journal-title":"Gut"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/00365521.2016.1250281","article-title":"Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma","volume":"52","author":"S Boyd","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-2006-925257","article-title":"Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis","volume":"38","author":"JJ Tischendorf","year":"2006","journal-title":"Endoscopy"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-1999-18","article-title":"Value of brush cytology for dominant strictures in primary sclerosing cholangitis","volume":"31","author":"CY Ponsioen","year":"1999","journal-title":"Endoscopy"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mge.2002.125105","article-title":"Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"56","author":"E Siqueira","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-2002-35298","article-title":"Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis","volume":"34","author":"B Lindberg","year":"2002","journal-title":"Endoscopy"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000326276","article-title":"Role of biliary brush cytology in primary sclerosing cholangitis","volume":"48","author":"A Lal","year":"2004","journal-title":"Acta Cytol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1309\/J030-JYPW-KQTH-CLNJ","article-title":"Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19\u20139 levels","volume":"124","author":"PS Furmanczyk","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"KM Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.mcg.0000210102.82241.de","article-title":"Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"40","author":"SL Moff","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2006.08.021","article-title":"Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures","volume":"131","author":"LE Moreno Luna","year":"2006","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1478-3231.2011.02672.x","article-title":"Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity","volume":"32","author":"L Halme","year":"2012","journal-title":"Liver Int"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1007\/s10620-013-2608-y","article-title":"ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients","volume":"58","author":"M Heif","year":"2013","journal-title":"Dig Dis Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.20524\/aog.2022.0701","article-title":"A comparison of balloon- versus stent-based approach for dominant strictures in primary sclerosing cholangitis: a meta-analysis","volume":"35","author":"AS Dhaliwal","year":"2022","journal-title":"Ann Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11901-017-0341-2","article-title":"Are dominant strictures in primary sclerosing cholangitis a risk factor for cholangiocarcinoma?","volume":"16","author":"RW Chapman","year":"2017","journal-title":"Curr Hepatol Rep"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/diagnostics10050268","article-title":"Role of peroral cholangioscopy in the diagnosis of primary sclerosing cholangitis","volume":"10","author":"T Fujisawa","year":"2020","journal-title":"Diagnostics (Basel)"}],"container-title":["Endoscopy International Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2236-7557.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T15:50:32Z","timestamp":1730821832000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2236-7557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":34,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,1,31]]},"published-print":{"date-parts":[[2024,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2236-7557","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2364-3722","2196-9736"],"issn-type":[{"value":"2364-3722","type":"print"},{"value":"2196-9736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,2]]},"published":{"date-parts":[[2024,1,2]]}}}